Circulating leptin levels in thyroid dysfunction: a systematic review and meta-analysis.

IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Shanshan Liu, Jun Ma, Leyuan Zhang, Yanlong Yang, Ziqi Han, Limin Tian
{"title":"Circulating leptin levels in thyroid dysfunction: a systematic review and meta-analysis.","authors":"Shanshan Liu, Jun Ma, Leyuan Zhang, Yanlong Yang, Ziqi Han, Limin Tian","doi":"10.1186/s12902-025-01943-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Leptin is an important regulator of energy homeostasis, analogous to thyroid hormone (TH). The purpose of this study was to investigate circulating leptin levels in thyroid dysfunction (TD) patients and the role of TH levels.</p><p><strong>Methods: </strong>The electronic databases PubMed, Embase, Cochrane Library, and Web of Science were independently searched by two researchers, from inception until February 3, 2024, and updated on February 15, 2025. Pooled standardized mean difference (SMD) with a 95% confidence interval (CI) was calculated by the random effects model.</p><p><strong>Results: </strong>Thirty-eight studies reported circulating leptin levels in TD and control with euthyroidism, 4295 subjects were included in total, of which 1277 were hypothyroidism, 540 were hyperthyroidism, and 2478 were control. Compared to euthyroidism, leptin levels were significantly higher in hypothyroidism, and not significantly altered in hyperthyroidism (SMD [95%CI] = 0.71 [0.38, 1.04] and -0.03 [-0.57, 0.51], respectively). The subgroup analysis indicated that, compared to euthyroidism, leptin levels were significantly higher in subjects regardless of overt and subclinical hypothyroidism (SMD [95%CI] = 0.76 [0.25, 1.26] and 0.41 [0.11, 0.70], respectively), and not significantly different in overt hyperthyroidism (SMD [95%CI] = -0.14 [-0.74, 0.45]). Furthermore, when compared to age-, gender-, and body mass index (BMI)-matched euthyroidism, leptin levels were significantly higher in hypothyroidism and had no significant difference in hyperthyroidism (SMD [95%CI] = 0.66 [0.24, 1.07] and -0.43 [-1.13, 0.27], respectively). A total of 16 studies analyzed the correlations between leptin levels and TH levels in TD, 488 were hypothyroidism and 206 were hyperthyroidism. Following correlation analysis, leptin levels displayed a positive correlation with thyroid-stimulating hormone (TSH) levels (r = 0.19) and a negative correlation with triiodothyronine (T3) levels (r = -0.40) in TD.</p><p><strong>Conclusion: </strong>Compared to euthyroidism, circulating leptin levels were significantly higher in hypothyroidism, and not significantly altered in hyperthyroidism. Besides, leptin levels in TD may be directly regulated by TSH and T3 levels, independent of BMI.</p><p><strong>Trial registration: </strong>CRD42024561055.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"25 1","pages":"140"},"PeriodicalIF":2.8000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12142830/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Endocrine Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12902-025-01943-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Leptin is an important regulator of energy homeostasis, analogous to thyroid hormone (TH). The purpose of this study was to investigate circulating leptin levels in thyroid dysfunction (TD) patients and the role of TH levels.

Methods: The electronic databases PubMed, Embase, Cochrane Library, and Web of Science were independently searched by two researchers, from inception until February 3, 2024, and updated on February 15, 2025. Pooled standardized mean difference (SMD) with a 95% confidence interval (CI) was calculated by the random effects model.

Results: Thirty-eight studies reported circulating leptin levels in TD and control with euthyroidism, 4295 subjects were included in total, of which 1277 were hypothyroidism, 540 were hyperthyroidism, and 2478 were control. Compared to euthyroidism, leptin levels were significantly higher in hypothyroidism, and not significantly altered in hyperthyroidism (SMD [95%CI] = 0.71 [0.38, 1.04] and -0.03 [-0.57, 0.51], respectively). The subgroup analysis indicated that, compared to euthyroidism, leptin levels were significantly higher in subjects regardless of overt and subclinical hypothyroidism (SMD [95%CI] = 0.76 [0.25, 1.26] and 0.41 [0.11, 0.70], respectively), and not significantly different in overt hyperthyroidism (SMD [95%CI] = -0.14 [-0.74, 0.45]). Furthermore, when compared to age-, gender-, and body mass index (BMI)-matched euthyroidism, leptin levels were significantly higher in hypothyroidism and had no significant difference in hyperthyroidism (SMD [95%CI] = 0.66 [0.24, 1.07] and -0.43 [-1.13, 0.27], respectively). A total of 16 studies analyzed the correlations between leptin levels and TH levels in TD, 488 were hypothyroidism and 206 were hyperthyroidism. Following correlation analysis, leptin levels displayed a positive correlation with thyroid-stimulating hormone (TSH) levels (r = 0.19) and a negative correlation with triiodothyronine (T3) levels (r = -0.40) in TD.

Conclusion: Compared to euthyroidism, circulating leptin levels were significantly higher in hypothyroidism, and not significantly altered in hyperthyroidism. Besides, leptin levels in TD may be directly regulated by TSH and T3 levels, independent of BMI.

Trial registration: CRD42024561055.

循环瘦素水平与甲状腺功能障碍:一项系统综述和荟萃分析。
目的:瘦素是一种重要的能量稳态调节剂,类似于甲状腺激素。本研究的目的是探讨循环瘦素水平在甲状腺功能障碍(TD)患者和TH水平的作用。方法:由两名研究人员独立检索PubMed、Embase、Cochrane Library和Web of Science等电子数据库,检索时间从建立到2024年2月3日,更新时间为2025年2月15日。采用随机效应模型计算具有95%置信区间(CI)的合并标准化平均差(SMD)。结果:38项研究报告了TD患者和甲状腺功能亢进对照组的循环瘦素水平,共纳入4295例受试者,其中甲状腺功能减退1277例,甲状腺功能亢进540例,对照组2478例。与甲状腺功能亢进患者相比,甲状腺功能减退患者瘦素水平显著升高,甲状腺功能亢进患者瘦素水平无显著变化(SMD [95%CI]分别= 0.71[0.38,1.04]和-0.03[-0.57,0.51])。亚组分析显示,与甲状腺功能正常者相比,无论是显性甲状腺功能减退还是亚临床甲状腺功能减退,瘦素水平均显著升高(SMD [95%CI]分别= 0.76[0.25,1.26]和0.41[0.11,0.70]),而显性甲状腺功能减退患者的瘦素水平差异无统计学意义(SMD [95%CI] = -0.14[-0.74, 0.45])。此外,与年龄、性别和体重指数(BMI)匹配的甲状腺功能亢进患者相比,甲状腺功能减退患者瘦素水平显著升高,甲状腺功能亢进患者瘦素水平无显著差异(SMD [95%CI]分别= 0.66[0.24,1.07]和-0.43[-1.13,0.27])。共有16项研究分析了TD患者瘦素水平与TH水平的相关性,其中488例为甲状腺功能减退,206例为甲状腺功能亢进。经相关分析,瘦素水平与TD患者促甲状腺激素(TSH)水平呈正相关(r = 0.19),与三碘甲状腺原氨酸(T3)水平呈负相关(r = -0.40)。结论:与甲状腺功能亢进患者相比,甲状腺功能减退患者的循环瘦素水平明显升高,而甲状腺功能亢进患者的循环瘦素水平无明显变化。此外,TD患者的瘦素水平可能受TSH和T3水平的直接调节,而不受BMI的影响。试验注册:CRD42024561055。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Endocrine Disorders
BMC Endocrine Disorders ENDOCRINOLOGY & METABOLISM-
CiteScore
4.40
自引率
0.00%
发文量
280
审稿时长
>12 weeks
期刊介绍: BMC Endocrine Disorders is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of endocrine disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信